CD8A and non-small cell lung carcinoma: Donnem et al. in the large study on about 800 non-small-cell lung cancer (NSCLC) patients concluded that the density of CD8+ cells in tumour infiltrating lymphocytes (TIL) is a strong independent factor for such clinical responses, like disease-free survival and overall survival [14].